natgillin/translations-raw huggingface dataset:
Gastrointestinal disorders such as, nausea, vomiting, diarrhoea and decreased appetite (Table 1) and abdominal pain (Table 3) occur most frequently during initiation of therapy with Jentadueto or metformin hydrochloride and resolve spontaneously in most cases.
Poremećaji probavnog sustava poput mučnine, povraćanja, proljeva i smanjenog apetita (Tablica 1) te bol u abdomenu (Tablica 3) najčešće se javljaju tijekom počinjanja liječenja Jentaduetom ili metforminkloridom te su u većini slučajeva spontano nestale.
Gastrointestinal disorders Uncommon:
Poremećaji probavnog sustava
Gastrointestinal disorders Uncommon: Nausea
Poremećaji probavnog sustava Manje često: Mučnina
Gastrointestinal disorders were less frequent in inadequately controlled patients compared to medically naïve patients.
Poremećaji probavnog sustava bili su manje učestali u neodgovarajuće kontroliranih bolesnika u usporedbi s bolesnicima koji nisu ranije primali terapiju lijekovima.
Gastrointestinal disorders*
ulceracije ili
Gastrointestinal disorders, such as nausea, vomiting, diarrhoea, pain in the abdomen, bloating, constipation, indigestion
Probavni poremećaji poput mučnine, povraćanja, proljeva, boli u trbuhu, nadutosti, zatvora i loše probave
Gastrointestinal disorders4
Poremećaji probavnog sustava4
Gastrointestinal disorders5
Poremećaji probavnog sustava 5
Gastrointestinal disorders:
Poremećaji probave:
Gastrointestinal disorders:
Poremećaji probavnog sustava
Gastrointestinal disorders:
Poremećaji probavnog sustava:
Gastrointestinal disorders:
Poremećaji živčanog sustava:
Gastrointestinal disorders: Anticholinergic medicinal products may decrease gastrointestinal motility and should be used with caution in patients with gastrointestinal obstructive disorders because of the risk of gastric retention.
Gastrointestinalni poremećaji: Antikolinergički lijekovi mogu usporiti gastrointestinalni motilitet i moraju se koristiti uz oprez u bolesnika s gastrointestinalnim opstruktivnim poremećajima zbog rizika od želučane retencije.
Gastrointestinal disorders: Common: nausea/vomiting
Poremećaji probavnog sustava: Često: mučnina/povraćanje
Gastrointestinal disorders: common: vomiting, diarrhoea, abdominal pain, nausea,
Poremećaji probavnog sustava: često: povraćanje, proljev, bol u abdomenu, mučnina,
Gastrointestinal disorders: Not known: pancreatitis, anorexia, diarrhoea, constipation, gastric irritation, sialadenitis, loss of appetite
Poremećaji probavnog sustava: Nepoznato: pankreatitis, anoreksija, proljev, konstipacija, iritacija želuca, sijaloadenitis, gubitak apetita
Gastrointestinal disorders: Obese patients [Body mass index (BMI) >30 kg/m2] treated with Benlysta reported higher rates of nausea, vomiting and diarrhoea relative to placebo, and compared with normal- weight patients (BMI ≥18.5 to ≤30 kg/m2).
Poremećaji probavnog sustava: Pretili bolesnici [indeks tjelesne mase (ITM) >30 kg/m2 liječeni lijekom Benlysta prijavili su veće stope mučnine, povraćanja i proljeva u odnosu na placebo, i u usporedbi s bolesnicima normalne težine (ITM ≥18,5 do ≤30 kg/m2).
Gastrointestinal disorders: Vomiting.
Poremećaji probavnog sustava: povraćanje.
Gastrointestinal Drugs
Gastrointestinalni lijekovi
Gastrointestinal events
gastrointestinalni događaji
Gastrointestinal events led to discontinuation in 0.6% of patients.
Gastrointestinalni događaji doveli su prekida liječenja u 0,6% bolesnika.
Gastrointestinal events were managed primarily with concomitant medicinal products including anti-emetic/anti-diarrhoeal medicinal products (in 84.8% of patients) and/or with dose reduction or interruption (in 33.0% of patients).
Gastrointestinalni događaji su se zbrinjavali u prvom redu istodobnom primjenom drugih lijekova uključujući antiemetike/antidijaroike (u 84,8% bolesnika) i/ili smanjenjima doze ili prekidima doziranja (u 33,0% bolesnika).
Gastrointestinal events: In patients who experience intolerance to therapy due to gastrointestinal side effects, patients should be reminded to take the medicinal product with food.
Probavne smetnje: Bolesnike koji ne podnose terapiju zbog gastrointestinalnih nuspojava treba podsjetiti da lijek uzimaju s hranom.
gastrointestinal fistula, oesophagitis
gastrointestinalna fistula, ezofagitis
gastrointestinal fistulak
malaksalost
Gastrointestinal haemorrhage
gastrointestinalna hemoragija
Gastrointestinal haemorrhage
Gastrointestinalno krvarenjePankreatitis
Gastrointestinal haemorrhage
krvarenje iz probavnog sustava
Gastrointestinal haemorrhage
Krvarenje u probavnom sustavu
Gastrointestinal haemorrhage
Trombocitopenija
Gastrointestinal haemorrhage (G3/4: 0.4%)
suhoća kože; deskvamacija
Gastrointestinal haemorrhage (inc mucosal)*, Abdominal distension, Dyspepsia, Oropharyngeal pain*, Gastritis*, Oral ulceration*, Abdominal discomfort, Dysphagia, Gastrointestinal inflammation*, Abdominal pain (inc gastrointestinal and splenic pain)*, Oral disorder*
Gastrointestinalno krvarenje (uključujući mukozno)*, distenzija abdomena, dispepsija, orofaringealna bol *, gastritis*, ulceracije u ustima*, nelagoda u abdomenu, disfagija, gastrointestinalna upala*, bol u abdomenu (uključujući gastrointestinalnu bol i bol slezene)*, poremećaj u ustima
Gastrointestinal haemorrhage (inc mucosal)*, Dyspepsia, Stomatitis*, Abdominal distension, Oropharyngeal pain*, Abdominal pain (inc gastrointestinal and splenic pain)*, Oral disorder*, Flatulence
gastrointestinalno krvarenje (uključujući mukozno)*, dispepsija, stomatitis*, distenzija abdomena, orofaringealna bol*, bolovi u abdomenu (uključujući gastrointestinalnu bol i bol slezene)*, poremećaj u ustima*, flatulencija
Gastrointestinal haemorrhage (including haematemesis, melaena, oesophageal haemorrhage, anal haemorrhage), Retroperitoneal haemorrhage, Gingival haemorrhage, Nausea
gastrointestinalno krvarenje (uključujući hematemezu, melenu, ezofagealno krvarenje, analno krvarenje), retroperitonealno krvarenje, gingivalno krvarenje, mučnina
Gastrointestinal haemorrhage (such as gastric haemorrhage, gastric ulcer haemorrhage, rectal haemorrhage, haematemesis, melaena, mouth haemorrhage),
Gastrointestinalno krvarenje (želučano krvarenje, krvarenje čira na želucu, rektalno krvarenje, hematemeza, melena, krvarenje u ustima),
Gastrointestinal haemorrhage events
epizode krvarenja u probavnom sustavu
Gastrointestinal haemorrhage eventsb
epizode krvarenja u probavnom sustavub
Gastrointestinal haemorrhage Gastrointentestinal perforation
Gastrointestinalno krvarenje Perforacija u probavnom sustavu
Gastrointestinal haemorrhage including gastrointestinal ulcer, duodenitis, gastritis and rectal haemorrhage, stomatitis and oral ulcers, faecal incontinence, constipation, dry mouth
Gastrointestinalno krvarenje, uključujući gastrointestinalni vrijed, duodenitis, gastritis i rektalno krvarenje, stomatitis, ulceracije usne šupljine, inkontinencija fecesa, konstipacija, suha usta
Gastrointestinal haemorrhage Pancreatitis Anorexia Dyspepsia Constipation Gastrointestinal disorder
Gastrointestinalna hemoragija Pankreatitis Anoreksija Dispepsija Konstipacija Gastrointestinalni poremećaj
Gastrointestinal haemorrhage*, intestinal obstruction*.
Gastrointestinalno krvarenje*, crijevna opstrukcija
Gastrointestinal haemorrhage,
krvarenje,
gastrointestinal haemorrhage, colitisb,c, constipation, gastroesophageal reflux disease, abdominal pain, mucosal inflammationd
gastrointestinalno krvarenje, kolitisb,c, konstipacija, gastroezofagealna refluksna bolest, bol u abdomenu, upala sluzniced
Gastrointestinal haemorrhage, Constipation, Upper abdominal pain, Dyspepsia, Flatulence,
gastrointestinalno krvarenje, konstipacija, bol u gornjem dijelu trbuha, dispepsija, flatulencija,
Gastrointestinal haemorrhage, Constipation, Upper abdominal pain, Dyspepsia, Flatulence, Dry mouth
gastrointestinalno krvarenje, konstipacija, bol u gornjem dijelu trbuha, dispepsija, flatulencija, suha usta
Gastrointestinal haemorrhage, diarrhoea, abdominal pain, dyspepsia
gastro- intestinalno krvarenje, proljev, bol u trbuhu, dispepsija
Gastrointestinal haemorrhage, diarrhoea, abdominal pain, dyspepsia
gastrointestinalno krvarenje, proljev, bol u trbuhu, dispepsija
Gastrointestinal haemorrhage, diarrhoea, abdominal pain, dyspepsia
krvarenje, proljev, bol u trbuhu, dispepsija
Gastrointestinal haemorrhage, diarrhoea, dyspepsia, gastroesophageal reflux, constipation.
Često: gastrointestinalno krvarenje, proljev, dispepsija, gastroezofagealni refluks, konstipacija
Gastrointestinal haemorrhage, peritonitis, ileus, colitis, gastric ulcer, duodenal ulcer, gastritis, oesophagitis, stomatitis, constipation, dyspepsia, flatulence
gastrointestinalno krvarenje, peritonitis, ileus, kolitis, želučani ulkus, ulkus dvanaesnika, gastritis, ezofagitis, stomatitis, konstipacija, dispepsija, flatulencija
Gastrointestinal haemorrhage, peritonitis, ileus, colitis, gastric ulcer, duodenal ulcer, gastritis, oesophagitis, stomatitis, constipation, dyspepsia, flatulence, eructation
gastrointestinalno krvarenje, peritonitis, ileus, kolitis, želučani ulkus, ulkus dvanaesnika, gastritis, ezofagitis, stomatitis, konstipacija, dispepsija, flatulencija, eruktacija
Gastrointestinal haemorrhage, stomatitis, gastrointestinal inflammation, flatulence, abdominal pain, dysphagia, abdominal discomfort, dyspepsia, dry mouth
gastrointestinalno krvarenje, stomatitis, gastrointestinalna upala, flatulencija, abdominalna bol, disfagija, abdominalna nelagoda, dispepsija, suha usta
Gastrointestinal haemorrhage7 Gastroenteritis Eructation Gastritis Dysphagia
gastrointestinalno krvarenje7 gastroenteritis podrigivanje gastritis
Gastrointestinal haemorrhage7 Gastroenteritis Stomatitis Eructation Gastritis Dysphagia Flatulence Breath odour
gastrointestinalno krvarenje7 gastroenteritis stomatitis podrigivanje gastritis disfagija flatulencija zadah iz usta
Gastrointestinal haemorrhagef
Gastrointestinalno krvarenje f
Gastrointestinal haemorrhageg, Diarrhoea, Nausea, Dyspepsia, Constipation
Krvarenja u probavnom sustavug, proljev, mučnina, dispepsija, konstipacija
Gastrointestinal hemorrhage, peptic ulcer disease (see section 4.4), dysphagia, dyspepsia, dysgeusia, glossodynia, flatulence
gastrointestinalno krvarenje, peptička ulkusna bolest (vidjeti dio 4.4), disfagija,
gastrointestinal infection
infekcije probavnog sustava
Gastrointestinal infections caused by bacteria
Gastrointestinalne infekcije izazvane bakterijama
GASTROINTESTINAL MOTILITY AGENTS
LIJEKOVI ZA GASTROINTESTINALNI MOTILITET
GASTROINTESTINAL MOTILITY AGENTS
LIJEKOVI ZA MOTILITET PROBAVNOG SUSTAVA
Gastrointestinal motility agents
Prokinetici
gastrointestinal motility disorders including untreated or severe gastroparesis, diverticulosis retention of gastric contents and abnormal or irregular bowel motion patients with a history of major gastrointestinal surgery
poremećajima motiliteta gastrointestinalnog trakta uključujući i neliječenu ili tešku gastroparezu, divertikulozu, retenciju želučanog sadržaja te neuobičajenu ili nepravilnu peristaltiku crijeva koji su prethodno podvrgnuti velikom operativnom zahvatu gastrointestinalnog trakta.
Gastrointestinal neoplasia including hepatobiliary tract
Gastrointestinalne neoplazije uključujući hepatobilijarni sustav
gastrointestinal obstructions (blockages of the digestive system).
gastrointestinalna opstrukcija (začepljenje probavnog sustava).
Gastrointestinal obstructive disorders (e.g. pyloric stenosis)
opstruktivni poremećaji probavnog sustava (npr. stenoza pilorusa)
Gastrointestinal pain
Gastrointestinalna bol
Gastrointestinal perforation
Gastrointestinalana perforacija
Gastrointestinal Perforation
Perforacije u probavnom sustavu
Gastrointestinal perforation (Gastrointestinal perforation, Intestinal perforation, Large intestine perforation).
Gastrointestinalna perforacija (gastrointestinalna perforacija, intestinalna perforacija, perforacija debelog crijeva).
Gastrointestinal perforation and fistula
Perforacija i fistula u probavnom sustavu
Gastrointestinal perforation and fistula formation
Gastrointestinalne perforacije i stvaranje fistula
Gastrointestinal perforation and fistulac,k
gastrointestinalna perforacija i fistulac,k
Gastrointestinal perforation in some cases leading to death has been observed in patients receiving MabThera for treatment of non-Hodgkgin lymphoma.
U bolesnika koji su primali lijek MabThera za liječenje ne-Hodgkinova limfoma zabilježene su gastrointestinalne perforacije, u nekim slučajevima sa smrtnim ishodom.
Gastrointestinal perforation in some cases leading to death has been observed in patients receiving MabThera for treatment of non-Hodgkin lymphoma.
U bolesnika koji su primali lijek MabThera za liječenje ne-Hodgkinova limfoma zabilježene su gastrointestinalne perforacije, u nekim slučajevima sa smrtnim ishodom.
Gastrointestinal perforation in some cases leading to death has been observed in patients receiving MabThera for treatment of Non-Hodgkin’s lymphoma (NHL).
U bolesnika koji su primali lijek MabThera za liječenje ne-Hodgkinova limfoma (NHL) zabilježene su gastrointestinalne perforacije, u nekim slučajevima sa smrtnim ishodom.
Gastrointestinal perforation* Gastrointestinal fistula
perforacija u probavnom sustavu* fistula u probavnom sustavu
Gastrointestinal perforation, oesophagitis, gastrointestinal infection, ileus, gastrointestinal obstruction, ascites, lip oedema, oesophageal spasm, gastric ulcer, gastroesophageal reflux disease, reflux gastritis, retroperitoneal fibrosis, gastrointestinal disorder, anal haemorrhage, haemorrhoids, salivary hypersecretion, retching, salivary gland disorder, cheilitis, aerophagia, eructation, glossodynia, oral pain, teeth brittle
gastrointestinalna perforacija, ezofagitis, gastrointestinalna infekcija, ileus, gastrointestinalna opstrukcija, ascites, edem usana, spazam jednjaka, čir na želucu, gastroezofagealna refluksna bolest, refluksni gastritis, retroperitonealna fibroza, gastrointestinalni poremećaj, analno krvarenje, hemoroidi, hipersekrecija sline, dizanje želuca, poremećaj žlijezda
Gastrointestinal perforation, oesophagitis, gastrointestinal infection, ileus, gastrointestinal obstruction, ascites, lip oedema, oesophageal spasm, gastric ulcer, gastroesophageal reflux disease, reflux gastritis, retroperitoneal fibrosis, gastrointestinal disorder, anal haemorrhage, haemorrhoids, salivary hypersecretion, retching, salivary gland disorder, cheilitis, aerophagia, eructation, glossodynia, oral pain, teeth brittle
gastrointestinalna perforacija, ezofagitis, gastrointestinalna infekcija, ileus, gastrointestinalna opstrukcija, ascites, edem usana, spazam jednjaka, čir na želucu, gastroezofagealna refluksna bolest, refluksni gastritis, retroperitonealna fibroza, gastrointestinalni poremećaj, analno krvarenje, hemoroidi, hipersekrecija sline, dizanje želuca, poremećaj žlijezda slinovnica, upala usana, aerofagija, podrigivanje, glosodinija, oralna bol, lomljivost zubi
Gastrointestinal perforation.
Gastrointestinalna perforacija.
Gastrointestinal perforation1, acute pancreatitis1
gastrointestinalna perforacija1, akutni pankreatitis1
Gastrointestinal perforationl (<1%)
gastrointestinalna perforacijal (<1%)
Gastrointestinal perforations
Perforacije u probavnom sustavu
Gastrointestinal perforations (see section 4.4).
gastrointestinalne perforacije (vidjeti dio 4.4)
Gastrointestinal perforations and fistula
Gastrointestinalne perforacije i fistule
Gastrointestinal perforations have been reported in clinical trials with an incidence of less than 1% in patients with non-squamous non-small cell lung cancer, up to 1.3% in patients with metastatic breast cancer, up to 2.0% in patients with metastatic renal cell cancer or in patients with ovarian cancer receiving front-line treatment, and up to 2.7% (including gastrointestinal fistula and abscess) in patients with metastatic colorectal cancer.
Gastrointestinalne perforacije su u kliničkim ispitivanjima prijavljene s incidencijom manjom od 1% u bolesnika s neskvamoznim karcinomom pluća nemalih stanica, najviše 1,3% u bolesnika s metastatskim karicinomom dojke, najviše 2,0% u bolesnika s metastatskim karcinomom bubrežnih stanica ili bolesnica s karcinomom jajnika koje su prvi puta liječene te u najviše 2,7% (uključujući gastrointestinalne fistule i apsces) bolesnika s metastatskim kolorektalnim karcinomom.
GASTROINTESTINAL PRODUCTS
LIJEKOVI ZA PROBAVNI SUSTAV
GASTROINTESTINAL PRODUCTS (PROPULSIVE)
GASTROINTESTINALNI LIJEKOVI (PROPULZIVI)
Gastrointestinal protectants and parenteral fluids, as appropriate, may be required for animals that experienced gastrointestinal or renal adverse reactions.
Za životinje koje imaju gastrointestinalne ili bubrežne nuspojave možda će biti potrebni odgovarajući gastrointestinalni protektivi i parenteralne tekućine.
Gastrointestinal reactions contributed to the reasons for early discontinuation from the trial for 4 (14%) patients.
Gastrointestinalne nuspojave su pridonijele prijevremenom prekidu sudjelovanja u ispitivanju u 4 (14%) bolesnika.
Gastrointestinal reactions such as nausea and vomiting as well as loss of appetite.
reakcije probavnog sustava, kao što su mučnina i povraćanje, kao i gubitak apetita
Gastrointestinal signs and symptoms (abdominal pain, nausea, vomiting, diarrhoea, flatulence)
Gastrointestinalni znakovi i simptomi (bol u abdomenu, mučnina, povraćanje, proljev, vjetrovi)
gastrointestinal signs and symptoms, vomiting, gastrointestinal and abdominal pains, gastrointestinal inflammatory conditions, gastrointestinal haemorrhages, gastrointestinal ulceration and perforation, ascites, stomatitis and ulceration, constipation, dyspeptic signs and symptoms, flatulence, bloating and distension, loose stools
gastrointestinalni znakovi i simptomi, povraćanje, gastrointestinalni i abdominalni bolovi, gastrointestinalna upalna stanja, gastrointestinala krvarenja, gastrointestinalne ulceracije i perforacija, ascites, stomatitis i ulceracija, zatvor, znakovi i simptomi dispepsije, flatulencija, nadutost i distenzija, mekane stolice
Gastrointestinal signs which include emesis, reduced or absent faeces and, in rare cases, soft faeces may be observed.
Mogu se uočiti gastrointestinalni znakovi koji uključuju povraćanje, smanjenje ili odsutnost feces te, u rijetkim slučajevima, meku feces.
gastrointestinal stenosis (narrowing of part of the digestive system).
gastrointestinalna stenoza (suženje dijela probavnog sustava).
gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel where there is uncontrolled growth of cells in the supporting tissues of these organs.
gastrointestinalnog stromalnog tumora (GIST), tipa raka želuca i crijeva kada postoji nekontrolirani rast stanica u potpornim tkivima ovih organa.
Gastrointestinal stromal tumours
Gastrointestinalni stromalni tumor
Gastrointestinal stromal tumours (GIST).
Gastrointestinalnih stromalnih tumora (GIST).
Gastrointestinal studies
Ispitivanja gastrointestinalnih učinaka
Gastrointestinal symptoms (including diarrhoea, vomiting and nausea)
gastrointestinalni simptomi (uključujući proljev, povraćanje i mučninu)
Gastrointestinal symptoms (such as diarrhoea, vomiting, abdominal pain, nausea)
Gastrointestinalni simptomi (poput proljeva, povraćanja, bola u abdomenu, mučnine)
Gastrointestinal symptoms including nausea, vomiting, diarrhoea and abdominal pain
gastrointestinalni simptomi, uključujući mučninu, povraćanje, proljev i bol u abdomenu
gastrointestinal symptoms including nausea, vomiting, diarrhoea and abdominal pain
imptomi probavnog sustava uključujući mučninu, povraćanje, proljev i bol u trbuhu
Gastrointestinal symptoms, diarrhoea, nausea
gastrointestinalni simptomi, proljev, mučnina
Gastrointestinal symptoms, nausea
gastrointestinalni simptomi, mučnina
Gastrointestinal symptoms2 Very common
probavne smetnje2 vrlo često
Gastrointestinal symptomsi,§
gastrointestinalni simptomii,§
Gastrointestinal toxicities are frequently reported with olaparib therapy and are generally low grade (CTCAE grade 1 or 2) and intermittent and can be managed by dose interruption, dose reduction and/or concomitant medicinal products (e.g. antiemetic therapy).
Toksičnosti u probavnom sustavu često su prijavljena nuspojava terapije olaparibom, a obično su niskog stupnja (1. ili 2. stupnja prema CTCAE kriterijima) i javljaju se povremeno te ih je moguće zbrinuti privremenim prekidom liječenja, smanjenjem doze i/ili istodobnom primjenom drugih lijekova (npr. antiemetika).
Gastrointestinal toxicity was dose-limiting in a single ascending dose study.
Gastrointestinalna toksičnost je bila ograničavajuća za dozu u ispitivanju povećavanja jednokratne doze.
Gastrointestinal toxicity, including nausea, diarrhoea, vomiting and constipation are very common with VELCADE treatment.
Gastrointestinalna toksičnost, uključujući mučninu, proljev, povraćanje i zatvor, vrlo su česti kod liječenja VELCADEom.
Gastrointestinal Toxicity:
Gastrointestinalna
Gastrointestinal tract
Probavni sustav
gastrointestinal tract and not to
traktu, a ne zbog promjena
Gastrointestinal tract Nausea, vomiting, diarrhoea, abdominal pain, mouth ulceration
Probavni sustav mučnina, povraćanje, proljev, bol u abdomenu, ulceracija u ustima
Gastrointestinal tract ulceration may be exacerbated by corticosteroids in animals given non-steroidal anti-inflammatory drugs.
U životinja kojima se daju nesteroidni protuupalni lijekovi može doći do pojačane ulceracije gastrointestinalnog trakta.
gastrointestinal tumours, melanoma
gastrointestinalni tumori, melanom
gastrointestinal ulcer
čir u probavnom sustavu
gastrointestinal ulcer
čir želuca ili crijeva
Gastrointestinal ulcer, including oesophageal ulcer
Gastrointestinalni ulkus, uključujući ezofagealni ulkus
Gastrointestinal ulcera
proktalgija
Gastrointestinal ulceration has been reported in animals treated with corticosteroids and gastrointestinal ulceration may be exacerbated by steroids in animals given non-steroidal anti- inflammatory drugs and in animals with spinal cord trauma.
Prijavljena je gastrointestinalna ulceracija u životinja koje su liječene kortikosteroidima, dok se gastrointestinalna ulceracija može pogoršati steroidima u životinja kojima se daju nesteroidni protuupalni lijekovi kao i u životinja s traumom kralježnične moždine.
Gastrointestinal ulceration was reported in rare cases.
Rijetko se prijavljuje gastrointestinalna ulceracija.
Gastrointestinal viral infection
Gastrointestinalna virusna infekcija
Gastrointestinal: diarrhea, bloody stool, abdominal pain, nausea, or vomiting
probavni sustav: proljev, krvava stolica, bol u trbuhu, mučnina ili povraćanje
Gastrooeosophageal reflux disease Abdominal tenderness
gastroezofagealna refluksna bolest abdominalna osjetljivost
Gastrooesophageal
flatulencija,
Gastrooesophageal reflux
Gastroezofagealni refluks
Gastrooesophageal reflux disease
gastroezofagealna refluksna bolest
Gastrooesophageal reflux disease
gastroezofagealna refluksna bolest,
gastrooesophageal reflux disease (1.8% vs 1.0%),
gastroezofagealna refluksna bolest (1,8% prema 1,0%),
Gastrooesophageal reflux disease (acid reflux)
Gastroezofagealna refluksna bolest (vraćanje kiselog sadržaja iz želuca
Gastrooesophageal reflux disease (acid reflux)
Gastroezofagealna refluksna bolest (vraćanje kiselog sadržaja iz želuca)
Gastrooesophageal reflux disease Abdominal distension
Gastroezofagealna refluksna bolest Distenzija abdomena
Gastrooesophageal reflux disease Proctalgia
Gastroezofagealna refluksna bolest Proktalgija
gastrooesophageal reflux disease, pancreatitis
gastroezofagealna refluksna bolest, pankreatitis
gastrooesophageal reflux disease, pancreatitis
gastrooezofagealna refluksna bolest, pankreatitis
Gastrooesophageal reflux disease, salivary hypersecretion, hypoaesthesia oral
gastroezofagealna refluksna bolest, hipersekrecija sline, oralna hipoestezija
Gastrooesophageal reflux disease, salivary hypersecretion, hypoaesthesia oral
gastroezofagealni refluks, hipersekrecija sline, oralna hipoestezija
Gastroresistant formulations containing substances sensitive for degradation in the stomach, such as proton pump inhibitors, should be taken at least 1 hour before or more than 4 hours after immediate-release exenatide injection.
Želučanootporni oblici koji sadrže tvari osjetljive na razgradnju u želucu, poput inhibitora protonske pumpe, treba uzimati najmanje 1 sat prije ili više od 4 sata nakon injekcije eksenatida s trenutnim oslobađanjem .